US4333131039
US4333131039
Hinge Health, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 8.3B EUR | 6.66B EUR | 2.98B EUR | 3.68B EUR |
Enterprise Value | 7.52B EUR | 6.38B EUR | 2.8B EUR | 3.48B EUR |
Valuation Multiples | ||||
Trailing P/E | 33.96x | 61.03x | -- | -- |
Forward P/E | 33.66x | -- | -- | -- |
Price to Sales | 11.53x | 9.24x | 4.61x | 7.93x |
Price to Book | 23.97x | 19.33x | 9.57x | 9.72x |
EV/Revenue | 10.45x | 8.86x | 4.33x | 7.49x |
EV/EBITDA | 78.63x | 64.8x | -- | -- |
Price to FCF (P/FCF) | 27.71x | 23.45x | 14.7x | 22.81x |
EV/FCF | 25.11x | 22.46x | 13.81x | 21.57x |
FCF Yield | 3.61% | 4.27% | 6.8% | 4.38% |